loading
前日終値:
$8.21
開ける:
$8.18
24時間の取引高:
79,632
Relative Volume:
0.59
時価総額:
$48.17M
収益:
-
当期純損益:
$-17.06M
株価収益率:
-0.1272
EPS:
-70.7173
ネットキャッシュフロー:
$-14.18M
1週間 パフォーマンス:
-16.34%
1か月 パフォーマンス:
-1.11%
6か月 パフォーマンス:
-85.83%
1年 パフォーマンス:
-98.61%
1日の値動き範囲:
Value
$7.72
$9.30
1週間の範囲:
Value
$7.72
$10.08
52週間の値動き範囲:
Value
$7.72
$744.00

Cns Pharmaceuticals Inc Stock (CNSP) Company Profile

Name
名前
Cns Pharmaceuticals Inc
Name
セクター
Healthcare (1168)
Name
電話
1-800-946-9185
Name
住所
2100 WEST LOOP SOUTH, HOUSTON
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-11-13
Name
最新のSEC提出書
Name
CNSP's Discussions on Twitter

CNSP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CNSP
Cns Pharmaceuticals Inc
8.975 48.17M 0 -17.06M -14.18M -70.72
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.72 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
566.92 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.70 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
589.68 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.66 31.99B 3.81B -644.79M -669.77M -6.24

Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-12-28 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-08-24 開始されました Ladenburg Thalmann Buy

Cns Pharmaceuticals Inc (CNSP) 最新ニュース

pulisher
Jul 23, 2025

What analysts say about CNS Pharmaceuticals Inc. stockFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals Inc. Stock Analysis and ForecastTremendous return rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is CNS Pharmaceuticals Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - beatles.ru

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

What drives CNS Pharmaceuticals Inc. stock priceFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured In Virtual Investor Summer Spotlight Conference - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals CEO Shares Brain Cancer Treatment Vision at Investor Conference | CNSP Stock News - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

CNS Pharmaceuticals To Carry Out 1-for-12 Reverse Stock Split On July 22nd, 2025 - 富途牛牛

Jul 20, 2025
pulisher
Jul 20, 2025

CNS Pharmaceuticals Implements 1-for-12 Reverse Stock Split to Consolidate Shares and Improve Market Position - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 01:04:34 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - Barchart.com

Jul 18, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals announces 1-for-12 reverse stock split - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals announces 1-for-12 reverse stock split By Investing.com - Investing.com UK

Jul 18, 2025
pulisher
Jul 18, 2025

Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

How CNS Pharmaceuticals Inc. stock performs during market volatility3x Growth Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

CNSP SEC FilingsCNS Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

What makes CNS Pharmaceuticals Inc. stock price move sharplySmart Money Trade Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform - Yahoo Finance

Jul 15, 2025
pulisher
Jul 10, 2025

Jazz Looks To Block Avadel From Asking For Sleep Drug OK - Law360

Jul 10, 2025
pulisher
Jul 10, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Highlights Lead Program In Virtual CEO Segment - Barchart.com

Jul 10, 2025
pulisher
Jul 09, 2025

CNS Pharmaceuticals: TPI 287 Shows Potential in Treating CNS Tumors, CEO Discusses Recent Clinical Data at Virtual Investor CEO Connect Segment - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

CNS Pharma CEO Shares Exclusive Insights on Novel Brain Cancer Treatment TPI 287 at Healthcare Leaders Meeting - Stock Titan

Jul 09, 2025
pulisher
Jul 09, 2025

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment - FinancialContent

Jul 09, 2025
pulisher
Jul 04, 2025

CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 2% – Here’s What Happened - Defense World

Jul 04, 2025
pulisher
Jun 25, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Highlights GBM Treatment Insights In KOL Segment Featuring Dr. Erin Dunbar - Barchart.com

Jun 25, 2025
pulisher
Jun 24, 2025

CNS Pharmaceuticals Inc. Sheds Light on GBM Treatment Advances in KOL Segment with Dr. Erin Dunbar - citybuzz -

Jun 24, 2025
pulisher
Jun 24, 2025

CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Featuring Dr. Erin Dunbar Discussing Glioblastoma Multiforme and Lead Product Candidate TPI 287 - AInvest

Jun 24, 2025
pulisher
Jun 14, 2025

Axsome Therapeutics’ SWOT analysis: stock’s potential in CNS market - Investing.com

Jun 14, 2025
pulisher
Jun 12, 2025

Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan

Jun 12, 2025
pulisher
Jun 12, 2025

Citadel Advisors LLC Takes Position in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Boosts Stake in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development - Yahoo Finance

Jun 10, 2025
pulisher
Jun 06, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit - Barchart.com

Jun 06, 2025

Cns Pharmaceuticals Inc (CNSP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.61
price up icon 3.24%
$36.53
price up icon 1.47%
$103.71
price up icon 0.18%
$27.51
price down icon 1.96%
$114.43
price down icon 0.13%
biotechnology ONC
$296.00
price up icon 0.50%
大文字化:     |  ボリューム (24 時間):